Summary
In rats, CH 29-717 inhibits basal and physiologically or chemically stimulated prolactin secretion. It is more potent than the standard bromocriptine.
Similar content being viewed by others
References
E. Flückiger and H. R. Wagner, Experientia24, 1130 (1968).
E. Flückiger, J.-M. Vigouret and H. R. Wagner, in: Prolactin, p. 111, Excerpta Medica, Amsterdam 1978.
E. Flückiger and E. Del Pozo, Handb. exp. Pharmac.49, 615 (1978).
E. Flückiger, in: Prolactin and Carcinogenesis, p. 162. Alpha Omega Alpha Publishing, Cardiff 1972.
J. T. Litchfield and F. Wilcoxon, J. Pharmac.96, 99 (1949).
M. Auskova, K. Rezabek, V. Zikan and M. Semonsky, Endocr. Exp.8, 51 (1974).
E. Flückiger, in: The Physiology of Mammary Gland, p. 56. University of Tokyo Press, Tokyo 1978.
E. Flückiger, Acta endocr., Kbh. suppl.216, 111 (1978).
E. Flückiger, in: The Pharmacology of the Hypothalamus, p. 150. MacMillan Press Ltd., London 1978.
R. Horowski and K. J. Gräf, Acta endocr., Kbh. suppl.199, 203 (1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Flückiger, E., Briner, U., Doepfner, W. et al. Prolactin secretion inhibition by a new 8a-amino-ergoline, CH 29-717. Experientia 34, 1330–1332 (1978). https://doi.org/10.1007/BF01981452
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01981452